A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi; expanding the use of Vi polysaccharide vaccine in southeast China: a cluster-randomized trial

BMC Public Health. 2005 May 18:5:49. doi: 10.1186/1471-2458-5-49.

Abstract

Background: One of the goals of this study was to learn the coverage, safety and logistics of a mass vaccination campaign against typhoid fever in children and adults using locally produced typhoid Vi polysaccharide (PS) and group A meningococcal PS vaccines in southern China.

Methods: The vaccination campaign targeted 118,588 persons in Hechi, Guangxi Province, aged between 5 to 60 years, in 2003. The study area was divided into 107 geographic clusters, which were randomly allocated to receive one of the single-dose parenteral vaccines. All aspects regarding vaccination logistics, feasibility and safety were documented and systematically recorded. Results of the logistics, feasibility and safety are reported.

Results: The campaign lasted 5 weeks and the overall vaccination coverage was 78%. On average, the 30 vaccine teams gave immunizations on 23 days. Vaccine rates were higher in those aged < or = 15 years (90%) than in adolescents and young adults (70%). Planned mop-up activities increased the coverage by 17%. The overall vaccine wastage was 11%. The cold chain was maintained and documented. 66 individuals reported of adverse events out of all vaccinees, where fever (21%), malaise (19%) and local redness (19%) were the major symptoms; no life-threatening event occurred. Three needle-sharp events were reported.

Conclusion: The mass immunization proved feasible and safe, and vaccine coverage was high. Emphasis should be placed on: injection safety measures, community involvement and incorporation of mop-up strategies into any vaccination campaign. School-based and all-age Vi mass immunizations programs are potentially important public health strategies for prevention of typhoid fever in high-risk populations in southern China.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antigens, Bacterial / administration & dosage*
  • Antigens, Bacterial / adverse effects
  • Child
  • China / epidemiology
  • Cluster Analysis
  • Feasibility Studies
  • Geography
  • Humans
  • Injections, Intramuscular
  • Injections, Subcutaneous
  • Mass Vaccination / organization & administration*
  • Meningitis, Meningococcal / prevention & control
  • Meningococcal Vaccines / administration & dosage
  • Meningococcal Vaccines / adverse effects
  • Middle Aged
  • Polysaccharides, Bacterial / administration & dosage*
  • Polysaccharides, Bacterial / adverse effects
  • Public Health Administration
  • Safety
  • Social Marketing
  • Typhoid Fever / epidemiology
  • Typhoid Fever / prevention & control*
  • Typhoid-Paratyphoid Vaccines / administration & dosage*
  • Typhoid-Paratyphoid Vaccines / adverse effects

Substances

  • Antigens, Bacterial
  • Meningococcal Vaccines
  • Polysaccharides, Bacterial
  • Typhoid-Paratyphoid Vaccines